211 related articles for article (PubMed ID: 8637231)
1. c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia.
Wisniewski D; Strife A; Berman E; Clarkson B
Leukemia; 1996 Feb; 10(2):229-37. PubMed ID: 8637231
[TBL] [Abstract][Full Text] [Related]
2. New understanding of the pathogenesis of CML: a prototype of early neoplasia.
Clarkson BD; Strife A; Wisniewski D; Lambek C; Carpino N
Leukemia; 1997 Sep; 11(9):1404-28. PubMed ID: 9305592
[TBL] [Abstract][Full Text] [Related]
3. A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations.
Wisniewski D; Strife A; Wojciechowicz D; Lambek C; Clarkson B
Leukemia; 1994 Apr; 8(4):688-93. PubMed ID: 8152267
[TBL] [Abstract][Full Text] [Related]
4. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
Cancer Res; 1993 Jan; 53(2):401-9. PubMed ID: 7678076
[TBL] [Abstract][Full Text] [Related]
5. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells.
Carpino N; Wisniewski D; Strife A; Marshak D; Kobayashi R; Stillman B; Clarkson B
Cell; 1997 Jan; 88(2):197-204. PubMed ID: 9008160
[TBL] [Abstract][Full Text] [Related]
6. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.
Clarkson B; Strife A; Wisniewski D; Lambek CL; Liu C
Leukemia; 2003 Jul; 17(7):1211-62. PubMed ID: 12835715
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.
Matulonis U; Salgia R; Okuda K; Druker B; Griffin JD
Exp Hematol; 1993 Oct; 21(11):1460-6. PubMed ID: 8405226
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase.
Miyazawa K; Hendrie PC; Mantel C; Wood K; Ashman LK; Broxmeyer HE
Exp Hematol; 1991 Dec; 19(11):1110-23. PubMed ID: 1721591
[TBL] [Abstract][Full Text] [Related]
9. p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.
Pierce A; Owen-Lynch PJ; Spooncer E; Dexter TM; Whetton AD
Oncogene; 1998 Aug; 17(5):667-72. PubMed ID: 9704934
[TBL] [Abstract][Full Text] [Related]
10. Steel factor-induced tyrosine phosphorylation in murine mast cells. Common elements with IL-3-induced signal transduction pathways.
Welham MJ; Schrader JW
J Immunol; 1992 Oct; 149(8):2772-83. PubMed ID: 1383327
[TBL] [Abstract][Full Text] [Related]
11. Detection of P210bcr-abl in mature granulocytes from Ph1-positive chronic myelogenous leukemia patients by an immunoblotting method.
Kuwao F; Takahashi I
Leukemia; 1993 Aug; 7(8):1168-73. PubMed ID: 8350617
[TBL] [Abstract][Full Text] [Related]
12. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
[TBL] [Abstract][Full Text] [Related]
13. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor and steel factor induce phosphorylation of both unique and overlapping signal transduction intermediates in a human factor-dependent hematopoietic cell line.
Hallek M; Druker B; Lepisto EM; Wood KW; Ernst TJ; Griffin JD
J Cell Physiol; 1992 Oct; 153(1):176-86. PubMed ID: 1381714
[TBL] [Abstract][Full Text] [Related]
15. P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation.
Wilson-Rawls J; Xie S; Liu J; Laneuville P; Arlinghaus RB
Cancer Res; 1996 Aug; 56(15):3426-30. PubMed ID: 8758906
[TBL] [Abstract][Full Text] [Related]
16. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.
Clarkson B; Strife A
Leukemia; 1993 Nov; 7(11):1683-721. PubMed ID: 8231240
[TBL] [Abstract][Full Text] [Related]
17. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
[TBL] [Abstract][Full Text] [Related]
18. Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors.
Ramaraj P; Singh H; Niu N; Chu S; Holtz M; Yee JK; Bhatia R
Cancer Res; 2004 Aug; 64(15):5322-31. PubMed ID: 15289338
[TBL] [Abstract][Full Text] [Related]
19. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
Diaz-Blanco E; Bruns I; Neumann F; Fischer JC; Graef T; Rosskopf M; Brors B; Pechtel S; Bork S; Koch A; Baer A; Rohr UP; Kobbe G; von Haeseler A; Gattermann N; Haas R; Kronenwett R
Leukemia; 2007 Mar; 21(3):494-504. PubMed ID: 17252012
[TBL] [Abstract][Full Text] [Related]
20. Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.
Strife A; Wisniewski D; Liu C; Lambek CL; Darzynkiewicz Z; Silver RT; Clarkson B
Mol Cancer Res; 2003 Jan; 1(3):176-85. PubMed ID: 12556557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]